These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Integration of 2-deoxy-2-[18F] fluoro-D-glucose PET/CT into clinical management of patients with Wegener's granulomatosis. Ozmen O, Tatci E, Gokcek A, Koksal D, Dadali Y, Ozaydin E, Arslan N. Ann Nucl Med; 2013 Dec; 27(10):907-15. PubMed ID: 24037685 [Abstract] [Full Text] [Related]
3. Characterization of F-18 Fluorodeoxyglucose PET/CT in Granulomatosis with Polyangiitis. Nelson DR, Johnson GB, Cartin-Ceba R, Specks U. Sarcoidosis Vasc Diffuse Lung Dis; 2016 Jan 18; 32(4):342-52. PubMed ID: 26847102 [Abstract] [Full Text] [Related]
4. Intense FDG uptake on PET/CT in the upper and lower respiratory system indicative of Wegener's granulomatosis. Aydin M, Akkoyunlu ME, Yakar F, Ergul N, Sezer M. Rev Esp Med Nucl Imagen Mol; 2014 Jan 18; 33(1):32-5. PubMed ID: 23680478 [Abstract] [Full Text] [Related]
5. Fluorine-18-fluorodeoxyglucose PET/CT rare finding of a unique multiorgan involvement of Wegener's granulomatosis. Almuhaideb A, Syed R, Iordanidou L, Saad Z, Bomanji J. Br J Radiol; 2011 Oct 18; 84(1006):e202-4. PubMed ID: 21933977 [Abstract] [Full Text] [Related]
11. Ferret thoracic anatomy by 2-deoxy-2-(18F)fluoro-D-glucose (18F-FDG) positron emission tomography/computed tomography (18F-FDG PET/CT) imaging. Wu A, Zheng H, Kraenzle J, Biller A, Vanover CD, Proctor M, Sherwood L, Steffen M, Ng C, Mollura DJ, Jonsson CB. ILAR J; 2012 Apr 18; 53(1):E9-21. PubMed ID: 23382267 [Abstract] [Full Text] [Related]
12. Utility of 18F-FDG PET/CT in the diagnosis and staging of extramammary Paget's disease. Tian Y, Wu HB, Li DL, Li HS, Zhou WL, Wang QS. Nucl Med Commun; 2015 Sep 18; 36(9):892-7. PubMed ID: 25932540 [Abstract] [Full Text] [Related]
13. (18)F-FDG PET imaging of granulomatosis with polyangiitis -Wegener's Syndrome. De Geeter F, Gykiere P. Hell J Nucl Med; 2016 Sep 18; 19(1):53-6. PubMed ID: 26929942 [Abstract] [Full Text] [Related]
14. Fluorodeoxyglucose positron emission tomography with computed tomography detects greater metabolic changes that are not represented by plain radiography for patients with osteonecrosis of the jaw. Fleisher KE, Raad RA, Rakheja R, Gupta V, Chan KC, Friedman KP, Mourtzikos KA, Janal M, Glickman RS. J Oral Maxillofac Surg; 2014 Oct 18; 72(10):1957-65. PubMed ID: 25053572 [Abstract] [Full Text] [Related]
15. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial. Anderson CM, Chang T, Graham MM, Marquardt MD, Button A, Smith BJ, Menda Y, Sun W, Pagedar NA, Buatti JM. Int J Radiat Oncol Biol Phys; 2015 Mar 01; 91(3):472-9. PubMed ID: 25680593 [Abstract] [Full Text] [Related]
16. Semiquantitative Analysis of the Biodistribution of the Combined ¹⁸F-NaF and ¹⁸F-FDG Administration for PET/CT Imaging. Minamimoto R, Mosci C, Jamali M, Barkhodari A, Habte F, Jackson T, Mittra E, Gambhir SS, Iagaru A. J Nucl Med; 2015 May 01; 56(5):688-94. PubMed ID: 25840978 [Abstract] [Full Text] [Related]
17. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions? Casneuf V, Delrue L, Kelles A, Van Damme N, Van Huysse J, Berrevoet F, De Vos M, Duyck P, Peeters M. Acta Gastroenterol Belg; 2007 May 01; 70(4):331-8. PubMed ID: 18330088 [Abstract] [Full Text] [Related]
18. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle. Mertens LS, Fioole-Bruining A, Vegt E, Vogel WV, van Rhijn BW, Horenblas S. BJU Int; 2013 Oct 01; 112(6):729-34. PubMed ID: 23790129 [Abstract] [Full Text] [Related]
19. [F-18]fluorodeoxyglucose positron emission tomography and positron emission tomography: computed tomography in recurrent and metastatic cholangiocarcinoma. Jadvar H, Henderson RW, Conti PS. J Comput Assist Tomogr; 2007 Oct 01; 31(2):223-8. PubMed ID: 17414758 [Abstract] [Full Text] [Related]
20. Predictive value of (18)F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study. Caobelli F, Alongi P, Evangelista L, Picchio M, Saladini G, Rensi M, Geatti O, Castello A, Laghai I, Popescu CE, Dolci C, Crivellaro C, Seghezzi S, Kirienko M, De Biasi V, Cocciolillo F, Quartuccio N, Young AIMN Working Group. Eur J Nucl Med Mol Imaging; 2016 Mar 01; 43(3):404-13. PubMed ID: 26381775 [Abstract] [Full Text] [Related] Page: [Next] [New Search]